You are currently viewing the editor's summary.
View Full TextLog in to view the full text
AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions.
Register for free to read this article
As a service to the community, this article is available for free. Existing users log in.
More options
Download and print this article for your personal scholarly, research, and educational use.
Buy a single issue of Science for just $15 USD.
The Immune Response in a Bind
Children with MeCP2 (methyl-CpG binding protein 2) duplication syndrome have severe neurological defects caused by the overexpression of the MECP2 gene, which modulates expression of genes that influence neuronal and brain function. Many of these children also have recurrent respiratory infections; however, the role of MECP2 duplication in the immune system has been unclear. Now, Yang et al. have found that MeCP2 duplication may affect T helper type 1 (TH1) immunity.
The authors examined patients with MECP2 duplication and found immunological abnormalities, including differences in memory T and B cells and NK cells. Indeed, mice that overexpress MeCP2 had an immunological defect as well. The immune system has evolved specialized functions to ward off particular types of infections. These MeCP2-overexpressing mice could not mount a sufficient TH1 response to control an infection by the parasite Leishmania major but could fight off an airway fungal infection—a TH2 response. Immune cells from children with MeCP2 duplication syndrome also had defects in the interferon-γ–mediated TH1 response. Yang et al. show that this defect may be caused by MeCP2-suppressing expression of IFN-γ in TH1 cells. This study paves the way for preventing infectious complications in children with MeCP2 duplication syndrome.
- Copyright © 2012, American Association for the Advancement of Science